Skip to content
Open access

Ovarian Reserve in Women of the Moscow Metropolis: First National Centile References for Anti Müllerian Hormone

2026 · Doctor Ru · 0 citations

TL;DR

For the first time, AMH centile reference values have been derived in a large non‑selective Russian population and are applicable to the individual assessment of ovarian reserve in clinical practice and to informed planning of reproductive behaviour.

Abstract

Aim. To establish population‑based centile references for anti‑Müllerian hormone (AMH) in Russian women of reproductive age and to estimate the prevalence of diminished ovarian reserve in a non‑selective sample drawn from the Moscow metropolis. Design. Retrospective cross‑sectional study. Materials and methods. A retrospective cross‑sectional analysis was performed on AMH screening results of 351 185 female residents of Moscow obtained in 2024 and 2025. The cohort included women participating in the municipal “Stanu Mamoy” (“I Will Become a Mother”) programme and women over 39 years not participating in the project. Body mass index, clinical and medical history and the district of residence within Moscow were also taken into account. AMH was measured by an automated chemiluminescent immunoassay. Diminished ovarian reserve was defined as an AMH level < 1.2 ng/mL (POSEIDON criteria). Statistical analysis included the Kruskal–Wallis H‑test with η² effect size calculation, pairwise comparisons using Dunn’s test with Bonferroni correction, and Pearson’s χ² test with Cramér’s V. Results. The median AMH level in the overall sample was 2.61 [1.36; 4.46] ng/mL. Diminished ovarian reserve was documented in 75 708 (21.6%) women. Age emerged as the principal determinant of AMH variability (η² = 0.150, corresponding to a large effect size). AMH centile curves (P₅, P₁₀, P₂₅, P₅₀, P₇₅, P₉₀, P₉₅) were constructed for five age groups: 18–24, 25–29, 30–34, 35–39 and over 39 years. The most clinically relevant finding was the intersection of the P₂₅ curve with the 1.2 ng/mL threshold at approximately 33 years. Inter‑district differences across Moscow administrative districts were statistically significant but clinically negligible (η² = 0.003). Conclusion. For the first time, AMH centile reference values have been derived in a large non‑selective Russian population. These references are applicable to the individual assessment of ovarian reserve in clinical practice and to informed planning of reproductive behaviour. Keywords: anti Müllerian hormone, ovarian reserve, centile curves, population screening, reproductive ageing, delayed motherhood, “Stanu Mamoy” (“I Will Become a Mother”) programme

Read PDF

Similar papers

Open access Sep 2026

Anti-Müllerian hormone is a poor predictor of pregnancy with and without assisted reproductive technology: A population-based register study of 43,269 Danish women.

OBJECTIVE Anti-Müllerian hormone (AMH) is widely used as a marker of ovarian reserve, but its predictive value for pregnancy remains uncertain. We aimed to evaluate whether pre-pregnancy AMH predicts pregnancy with or without assisted reproductive technology (ART). MATERIALS AND METHODS This population-based register...

Maja Vigstedt, Freja Rueholm Klok, L. Prætorius et al. · 0 citations
Review 2026

Experience of large-scale AMH screening within the “Becoming a Mother” project in Moscow: integrating ovarian reserve testing into outpatient practice

Declining birth rates in large cities and delayed motherhood require innovative approaches to maintaining the population’s reproductive health. The “Becoming a Mother” project (Moscow, 2024–2025) provides a unique experience of integrating anti-Müllerian hormone (AMH) screening into outpatient obstetrics and gynecology...

Alexey Yu. Abramov, V. Radzinsky, A. Olenev et al. · 0 citations
Aug 2026

COMPARATIVE ANALYSIS OF ANTI-MULLERIAN HORMONE (AMH) AND FERTILITY IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME (PCOS)

The findings of this study reinforce the importance of incorporating AMH into the clinical evaluation of women of reproductive age and highlight the need to combine this parameter with clinical and imaging data for a more accurate diagnosis.

Mergime Abduli, Qefajet Murseli, S. Memishi · 0 citations
Open access Oct 2026

Variations in Anti-Müllerian Hormone (AMH) and Vitamin D Levels in Patients Seeking Treatment for Infertility in Abidjan

Background: Anti-Müllerian hormone (AMH), produced by granulosa cells, is a key biomarker of ovarian follicular development and female fertility. In hormonal physiology, vitamin D is thought to play a role in biological processes crucial to fertility by helping to regulate genes involved in AMH production. Inadequate v...

C. Kouamé-Dia, C. Yao-Yapo, Bénédicte Koné-Dakouri et al. · 0 citations
Open access Aug 2026

Trends in Anti‐Müllerian Hormone (AMH) Testing for Fertility Assessment in Australian General Practice, 2011–2021: A Retrospective Open Cohort Study

ABSTRACT Background Anti‐Müllerian hormone (AMH) tests are often promoted as a measure of fertility; however, AMH adds limited predictive value beyond age alone for estimating the likelihood of live birth in couples trying to conceive. Aims This study aimed to examine longitudinal trends in the rate of AMH testing for...

G. M. Kassie, T. Copp, Sarah Lensen et al. · 0 citations
Open access Aug 2026

Serum spexin levels in women with diminished ovarian reserve: a prospective case–control study

Background Spexin is a recently identified neuropeptide that modulates the hypothalamic–pituitary–gonadal axis and has been shown to regulate granulosa cell function. Although circulating spexin levels decline with age and metabolic dysregulation, its relationship with ovarian reserve has not been investigated. This st...

Rumeysa Nur Ozkan, I. Dağ, A. Bestel · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.